focus -WSS

focus

author：fashion 2025-10-02 18:48:55 - browse：29967

Is biotech back from its downturn? Can Nvidia solve biology? And is it wise to do a deal on a party bus?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Recording from the J.P. Morgan Healthcare Conference, we discuss how a spate of deals and some intermittent sunshine seem to have brightened the outlook for biotech at the outset of 2024. We also talk about the latest twist in the Sarepta Therapeutics saga, a ubiquitous dealmaker, and life on the party circuit.

For more on what we cover, here’s the news on Sarepta; here’s more on Nvidia; here’s the story on Centerview; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： Congress gives doctors Medicare pay bump

WSS

Will General Catalyst be the first of many hospital takeovers?

FDA approves potent Eli Lilly obesity drug, Zepbound

Flu vaccine offering decent levels of protection this winter, new data show

Don't let 'shelved assets' gather dust. Make them into new lifesaving drugs

Kenai launches with $82 million for Parkinson’s stem cell therapy

UCSF medical school apologizes for unethical prisoner experiments

leisure time

focus

Wikipedia

Alkermes shareholders re

Will General Catalyst be the first of many hospital takeovers?

Apple is now the first public company to be valued at $3 trillion

House looks to weaken Medicare negotiation

United colonoscopy coverage change 'may cost lives,' doctors say

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

Continuity nursing helped my family in our darkest PICU moments

FogPharma raises $145 million in rare Series E round

At least 13 dead in Texas as scorching temps continue

House looks to weaken Medicare negotiation

hotspot

Readout LOUD Podcast: Legal insider trading, booming biotech stocks

Medicare solvency divides Republicans at the presidential debate

RSV vaccines may be linked to small increased risk of developing GBS

An inside look at PIPEs, biotech's buzzy new financing tool

How to fix the rural physician shortage in the U.S.

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

knowledge

hotspot

knowledge

leisure time